ENANTA PHARMACEUTICALS, INC: 10-K filed 2025-11-19
What ENANTA PHARMACEUTICALS, INC reported in its annual report filed 2025-11-19 (fiscal FY 2025): 45 published measures, 115 facts as tagged in accession 0001193125-25-288121.
This filing
- Form
- 10-K (annual report)
- Filed
- 2025-11-19
- Fiscal period
- fiscal FY 2025
- Accession
- 0001193125-25-288121 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ENANTA PHARMACEUTICALS, INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 280,732,000 | USD | |
| At 2024-09-30 | 376,652,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 216,015,000 | USD | |
| At 2024-09-30 | 247,838,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 64,717,000 | USD | |
| At 2024-09-30 | 128,814,000 | USD | |
| At 2023-09-30 | 216,735,000 | USD | |
| At 2022-09-30 | 321,334,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 32,298,000 | USD | |
| At 2024-09-30 | 37,233,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -81,889,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -116,045,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -133,816,000 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -19,272,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -78,764,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -103,154,000 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 12,896,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 17,948,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 9,058,000 | USD | 365 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 65,324,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 67,635,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 79,204,000 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -26,618,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -27,626,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 198,126,000 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 40,347,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 58,235,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -53,578,000 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | -404,929,000 | USD | |
| At 2024-09-30 | -323,040,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 21,336 | shares | 365 |
| 2023-10-01 to 2024-09-30 | 21,157 | shares | 366 |
| 2022-10-01 to 2023-09-30 | 20,969 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 21,336 | shares | 365 |
| 2023-10-01 to 2024-09-30 | 21,157 | shares | 366 |
| 2022-10-01 to 2023-09-30 | 20,969 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -3.84 | USD/shares | 365 |
| 2023-10-01 to 2024-09-30 | -5.48 | USD/shares | 366 |
| 2022-10-01 to 2023-09-30 | -6.38 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -3.84 | USD/shares | 365 |
| 2023-10-01 to 2024-09-30 | -5.48 | USD/shares | 366 |
| 2022-10-01 to 2023-09-30 | -6.38 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -1,660,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -1,743,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 2,821,000 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 35,395,000 | USD | |
| At 2024-09-30 | 32,688,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 18,565,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 26,795,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 28,216,000 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -85,349,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -121,691,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -137,207,000 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 204,336,000 | USD | |
| At 2024-09-30 | 299,852,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 48,555,000 | USD | |
| At 2024-09-30 | 57,535,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,948,000 | USD | |
| At 2024-09-30 | 8,002,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 6,882,000 | USD | |
| At 2024-09-30 | 6,646,000 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 106,740,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 131,476,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 163,524,000 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 21,387,000 | shares | |
| At 2024-09-30 | 21,194,000 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | -339,000 | USD | |
| At 2024-09-30 | 302,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 37,549,000 | USD | |
| At 2024-09-30 | 40,658,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 57,903,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 59,200,000 | USD | |
| At 2024-09-30 | 57,735,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 23,805,000 | USD | |
| At 2024-09-30 | 25,047,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 92,000 | USD | |
| At 2024-09-30 | 94,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 260,000 | USD | |
| At 2024-09-30 | 231,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 12,751,000 | USD | |
| At 2024-09-30 | 13,547,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 8,590,000 | USD | |
| At 2024-09-30 | 12,413,000 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 11,984,000 | USD | |
| At 2024-09-30 | 14,151,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -83,549,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -117,788,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -130,995,000 | USD | 365 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -81,889,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -116,045,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -133,816,000 | USD | 365 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -82,530,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -114,569,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -131,266,000 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 43,933,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 57,850,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 52,887,000 | USD | 365 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 7,681,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 10,940,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 5,148,000 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 1,800,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 3,903,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 6,212,000 | USD | 365 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 8,794,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 11,710,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 1,987,000 | USD | 365 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 9,856,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | 8,283,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | 6,586,000 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | 236,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -1,968,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -11,704,000 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-10-01 to 2025-09-30 | -1,311,000 | USD | 365 |
| 2023-10-01 to 2024-09-30 | -414,000 | USD | 366 |
| 2022-10-01 to 2023-09-30 | -1,151,000 | USD | 365 |
Inspect the source
- Entity
- ENANTA PHARMACEUTICALS, INC / CIK 0001177648
- Captured
- 2026-09-20T07:44:57.103Z
- SEC response SHA-256
80fddde6209a85211c99bf9c410a8d05c029ccda8597cc49f72b1775c18d6d7b
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001177648.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))